Dextenza® (dexamethasone ophthalmic insert) – New indication
October 11, 2021 - Ocular Therapeutix announced the FDA approval of Dextenza (dexamethasone ophthalmic insert), for the treatment of ocular itching associated with allergic conjunctivitis.
Download PDF
